IL6 and depressive symptom measurement: To aid interpretation, Figure 1 presents a concise conceptual model linking cancer and T2DM (via systemic inflammation/IL-6, TNF-α) to neuroinflammatory activation, psychiatric distress (HADS Anxiety/Depression), and functional decline (ECOG), including measured and unmeasured factors.